SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2532Any estimate on patient size? I think one of the analysts wasn't too optimiFelix B-10/16/2018
2531Dupi third indication (chronic rhinosinusitis with nasal polyps) : investor.regeMiljenko Zuanic-10/16/2018
2530To be honest I do not understand this trial (with Fasinumab) at all? Are they inMiljenko Zuanic-10/13/2018
2529Good question, I wouldn't have noticed. Guess you ask an orthopedist/neurolscaram(o)uche-10/12/2018
2528How does peripheral nerve function indication differentiate from "regular&qMiljenko Zuanic-10/12/2018
2527Canaccord and MS purposely released "neutral" report today,...countingMiljenko Zuanic-10/11/2018
2526Wasn't clear on the article if they stopped the steroid treatment after dupiFelix B-10/11/2018
2525Dupi "side effects" medicalxpress.comMiljenko Zuanic-10/10/2018
2524REGN at ESMO: cslide.ctimeetingtech.com CSCC: " The median duration of resMiljenko Zuanic-10/9/2018
2523Last weak of 3Q Dupi TRx/NRx are out. Projecting ~$210M US sale (~40-45 exUS), sMiljenko Zuanic-10/5/2018
2522Please,.... it was 15$ move from nowhere....someone was hoping more on Friday..Miljenko Zuanic-9/30/2018
2521How do you know they know and if so who? How does price compare to the other PDFelix B-9/29/2018
2520For BT cancer drug, with unmet needs, "expected" is relative. REGN didMiljenko Zuanic-9/29/2018
2519Approved a month earlier than expected...Felix B-9/29/2018
2518Cemiplimab approved: investor.regeneron.com Now I know why there was spike ($1Miljenko Zuanic-9/28/2018
2517Anyone can draw lines on chart and speculate on S.-Price movements! It is way faMiljenko Zuanic-9/28/2018
2516bizjournals.com Step by step, their foundation and roots are going deep at RensMiljenko Zuanic-9/27/2018
2515Here comes old sucker, ....he has no grandson to pass his REGN shares???? invesMiljenko Zuanic-9/25/2018
2514RE:ANAB. anti-IL33 Abs (ANB020, Etokimab) competitor to REGN3500 finance.yahoo.Miljenko Zuanic-9/24/2018
2513Fast track for ADVM-022, but no weight so far: investors.adverum.comMiljenko Zuanic-9/19/2018
2512Nice Eylea article: thenonconsensus.comMiljenko Zuanic-9/19/2018
2511Thanks Tuck. Inhales Antican would be for asthma population, ..however I do notMiljenko Zuanic-9/18/2018
2510Preclinical data from Pieris' inhaled IL-4Ra antagonist, from ERS: >>tuck-9/18/2018
2509Bit's me!Miljenko Zuanic-9/14/2018
2508why so slow?Felix B-9/14/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News